Topiramate for Migraine Prevention in Adolescents: A Pooled Analysis of Efficacy and Safety
- 9 November 2006
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 46 (10), 1503-1510
- https://doi.org/10.1111/j.1526-4610.2006.00610.x
Abstract
To characterize the efficacy and safety of topiramate for migraine prevention in adolescents from 3 randomized, 26-week, double-blind, placebo-controlled trials. Limited information is available regarding the efficacy and safety of prophylactic medications for treatment of adolescent migraine, a significant health problem. In studies that included adults and children, topiramate 100 and 200 mg/day were effective and generally well-tolerated in the prevention of migraine headache. We performed a post hoc subset analysis of the efficacy and safety data from the 51 patients, ages 12-17 years, enrolled in 3 pivotal trials of topiramate for migraine prophylaxis. Daily treatment with topiramate 50, 100, and 200 mg for 26 weeks reduced monthly migraine frequency from baseline 46% (P= .07), 63% (P= .02), and 65% (P= .04), respectively, compared with placebo (16%). Similarly, topiramate reduced both the monthly mean number of migraine days (1, 4, and 5 days for topiramate 50, 100, and 200 mg/day, respectively, vs 1 day for placebo) and percentage of days during which acute migraine medications were administered (59%, 54%, and 67% for topiramate 50, 100, and 200 mg/day, respectively, vs 42% for placebo), although the treatment differences did not reach nominal statistical significance. Topiramate 200 mg/day did not appear to offer greater efficacy than 100 mg/day. Treatment was generally well-tolerated, although adverse events were most frequent in the 200 mg/day dose group. This post hoc subset analysis suggests that topiramate 100 and 200 mg/day, and possibly 50 mg/day, administered prophylactically for 26 weeks may reduce migraine in adolescents.Keywords
This publication has 21 references indexed in Scilit:
- Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled TrialHeadache: The Journal of Head and Face Pain, 2005
- French guidelines for the diagnosis and management of migraine in adults and childrenClinical Therapeutics, 2004
- Treatment of paediatric headacheExpert Opinion on Pharmacotherapy, 2002
- Effectiveness of Topiramate in the Prevention of Childhood HeadachesHeadache: The Journal of Head and Face Pain, 2002
- Topical Review : Preventive Therapy in Pediatric MigraineJournal of Child Neurology, 2001
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Periodic syndrome and migraine in children and adolescentsThe Italian Journal of Neurological Sciences, 1997
- Impact of Migraine in the United States: Data from the National Health Interview SurveyHeadache: The Journal of Head and Face Pain, 1993
- EPIDEMIOLOGY OF HEADACHE AND CHILDHOOD MIGRAINE IN AN URBAN GENERAL PRACTICE USING AD HOC, VAHLQUIST AND IHS CRITERIADevelopmental Medicine and Child Neurology, 1992
- An epidemiologic study of headache among adolescents and young adultsPublished by American Medical Association (AMA) ,1989